Mayr Jakob, Kurnoth Anna, Koenemann Nora, Röttinger Timon, Lisitano Leonhard, Mayr Edgar, Fenwick Annabel
Zentrum für Unfallchirurgie und Orthopädie, Klinikum Ingolstadt GmbH, Krumenauerstraße 25, 85049, Ingolstadt, Deutschland.
Klinik für Unfallchirurgie, Orthopädie, Plastische- und Handchirurgie, Universitätsklinikum Augsburg, Stenglinstraße 2, 86156, Augsburg, Deutschland.
Unfallchirurgie (Heidelb). 2025 May 14. doi: 10.1007/s00113-025-01572-z.
The global COVID-19 pandemic led to excess mortality, especially for vulnerable older patients with simultaneous comorbidities. Patients with proximal femoral fractures already have a high mortality risk of up to 30% during the first postoperative year. The purpose of this study was not only to investigate the impact of COVID-19 on the mortality of patients tested positive but also of negatively tested patients with proximal femoral fractures.
A single center cohort study of 2186 patients (mean age 79.8 years) who were surgically treated for a proximal femoral fracture at a level I trauma center was retrospectively carried out. The mortality and complication rates before the COVID-19 pandemic (January 2016-February 2020) and during the pandemic (March 2020-October 2021) were compared. A standardized treatment protocol was carried out during the total observational period. Orthogeriatric co-management was negatively impaired by the pandemic. Patient data, COVID-19 infections, surgical procedure, time from admission to surgery, postoperative complications and mortality were analyzed.
The pandemic group included 596 patients with an average age of 79.7 years. During the pandemic 26 patients were tested positive for COVID-19 (18 women, 8 men, average age 81.4 years, minimum 63 years, maximum 99 years, SD 9 years). Patients who tested positive for COVID-19 had more comorbidities than COVID-19 negative patients during the same period (Charlson comorbidity index, CCI 6.26 vs.5.25 points p < 0.037). The prepandemic control group consisted of 1590 patients with an average age of 79.9 years and a mean CCI of 5.86 points. Patients tested positive had a much longer hospitalization and a longer duration on the intensive care unit (p < 0.001) and a complication rate of 62.5%, especially due to the occurrence of pneumonia (p < 0.001). The mortality rate during the pandemic did not differ between patients tested positive or patients tested negative but was significantly higher for both groups in comparison to the period before the pandemic (pandemic 14% vs. 15.4%, before the pandemic 3.1%).
Patients suffering from COVID-19 infection and proximal femoral fractures have a high risk of complications and a high mortality. The total increase in mortality for all patients with critical injuries, such as hip fractures during the pandemic emphasizes the importance of early mobilization and orthogeriatric co-management, which was discontinued during the pandemic and the lockdown.
全球新冠疫情导致了超额死亡率,尤其是对于患有多种合并症的脆弱老年患者。股骨近端骨折患者在术后第一年的死亡风险高达30%。本研究的目的不仅是调查新冠病毒对新冠病毒检测呈阳性患者死亡率的影响,还包括对新冠病毒检测呈阴性的股骨近端骨折患者死亡率的影响。
对在一级创伤中心接受股骨近端骨折手术治疗的2186例患者(平均年龄79.8岁)进行了一项单中心队列研究。回顾性比较了新冠疫情之前(2016年1月至2020年2月)和疫情期间(2020年3月至2021年10月)的死亡率和并发症发生率。在整个观察期内执行标准化治疗方案。疫情对骨科老年联合管理产生了负面影响。分析了患者数据、新冠病毒感染情况、手术过程、入院至手术时间、术后并发症和死亡率。
疫情组包括596例患者,平均年龄79.7岁。疫情期间,26例患者新冠病毒检测呈阳性(18名女性,8名男性,平均年龄81.4岁,最小63岁,最大99岁,标准差9岁)。与同期新冠病毒检测呈阴性的患者相比,新冠病毒检测呈阳性的患者合并症更多(查尔森合并症指数,CCI 6.26对5.25分,p<0.037)。疫情前对照组由1590例患者组成,平均年龄79.9岁,平均CCI为5.86分。检测呈阳性的患者住院时间和在重症监护病房的时间长得多(p<0.001),并发症发生率为62.5%,尤其是由于肺炎的发生(p<0.001)。疫情期间,检测呈阳性的患者和检测呈阴性的患者死亡率没有差异,但与疫情前相比,两组的死亡率均显著更高(疫情期间14%对15.4%,疫情前3.1%)。
感染新冠病毒且患有股骨近端骨折的患者并发症风险高、死亡率高。疫情期间,所有重伤患者(如髋部骨折患者)的总死亡率上升凸显了早期活动和骨科老年联合管理的重要性。在疫情和封锁期间,这一管理方式被中断。